tampa criminal attorney: October 2018

Thank you for registering at PC Games Hardware! You've at www.pcgameshardware.de registered with the following data: Username: sqdgsqdgsqdg You are now a member of a huge, ever-growing and active community. Please follow our Conditions and Privacy Statement . Click now to confirm this link, your registration in the Community: finish the registration Please If the above link is not clickable or registration by clicking on this link could not be completed correctly, copy the following URL with no spaces or breaks in the address bar of your browser and then confirm with the Enter key: https://login.pcgameshardware.de/registration/pcghconnect.cfm?noPrest&unlock&uid=3239585&tid=1366698 Besides, you have a profile: Present yourself in your profile and show your own avatar! Take part in the active forum life! Rate games and articles from editors and other users! Write own tests readers! Parts other users on blogs with your personal opinion! Find new friends and stay with our friendship function in contact By calling the links above, you confirm that you accept the conditions laid down for the use of the online community. Without this confirmation, the use of the community is not possible! Please depositories your data well, because for you to get access to the interactive features of PC Games Hardware and can for example easily in our contests and vote in polls. This email keep well and do not give your login information on! Note: It is possible that the link has been wrapped from your mail program. We ask you to fully enter the link in this case in the URL line of your browser and press Enter. We wish you a lot of fun! Your Community Team! -------------------------------------------------- -------------------------------------- Computec Media GmbH Registered office and register court: FÃ¼rth (HRB 14364) Managing Director: Hans Ippisch (Chairman), Rainer Rosenbusch Chairman of the Supervisory Board: JÃ¼rg Marquard Sales tax identification number: DE 812575276

posted by Isaac Hobart at 11:04 AM 0 comments

Halloween Predator Warning

Tuesday, October 30, 2018

Important Halloween
Parent

Information

shared with anyone not directly involved in the hiring process. The Hamilton Police Department will also not share the information with me, except in response to a court order. I understand that my failure to cooperate fully in all facets of the background investigation will result in my immediate disqualification from further consideration for the position of Police Officer for the Hamilton Police Department. Signature of Applicant ____________________________________ Date _______________ Subscribed and Sworn to before me this _______ day of ____________, ______. Notary Public in and for said County of ________________, State of ___________________ Notary Public Signature _______________________________________________________ plication Packet Page: 32 CHILD SUPPORT Please mark the appropriate response. Failure to mark one of the three statements will result in the denial of your application. _____ I am not subject to a court order for the support of a child. _____ I am subject to a court order for the support of one or more children and I am in compliance with the order; or I am in compliance with a plan approved by the County Attorney (or other public agency) enforcing the order for the repayment of the amount owed, pursuant to the order. _____ I am subject to a court order for the support of one or more children and I am NOT in compliance with the order or plan approved by the County Attorney (or other public agency), enforcing the order for the repayment of the amount owed, pursuant to the order. Applicant's Social Security Number: ___________________________ Signature of Applicant _______________________________ Date ____________________ Subscribed and Sworn to before me this ______ day of ________________, ______. Notary Public for said County of ___________________, State of _____________________ Notary Public Signature_______________________________________________________ pplication Packet Page: 33 AUTHORIZATION TO RELEASE INFORMATION Name of Applicant ________________________________________________________ Date of Birth _________________________________________________________ Social Security Number______________________________________________________ As an applicant for the position of Police Officer with the Hamilton Police Department I am required to undergo a background investigation for use in determining my qualifications and suitability to be a police officer. I realize that this Department will NOT release the information provided to them to any person, including myself. The information submitted to this Department is confidential and will be used only for investigation of my suitability for law enforcement employment. Toward this end, I authorize release to the Hamilton Police Department of any and all information that you may have concerning me, including information of a confidential or privileged nature. I hereby authorize all my previous employers, physicians, and professionals who may have examined or treated me, friends, acquaintances, credit reporting services, public agencies, and all others to furnish the Hamilton Police Department any and all information they may have concerning me. I hereby release you, your organization, or others, from liability or damage, which may result from furnishing the information requested. You may be contacted by mail, by a background investigator with the Hamilton Police Department, or both. I further authorize that a photocopy of this Authorization to Release Information form shall be for all intents and purposes, as valid as the original. I authorize you to retain a copy of this form for your files. This release is valid for a period of one (1) year of the date of my signature. Signature of Applicant________________________________ Date_______________ Subscribed and Sworn to before me this ___________ day of __________________, _____ Notary Public in and for said County of _______________, State of ___________________ Notary Public Signature ______________________________________________________

posted by Isaac Hobart at 10:38 AM 0 comments

Confirmation us-concealed

Monday, October 29, 2018

posted by Isaac Hobart at 9:33 AM 0 comments

Confirmation us-concealed

posted by Isaac Hobart at 9:31 AM 0 comments

Confirmation nqdc

Sunday, October 28, 2018

hello 74.208.146.48G3TUP<div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/confirmation-nqdc.html" title="permanent link">8:03 PM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/889724116269762035"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/889724116269762035;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=889724116269762035" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=889724116269762035&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="3328075162971576287"></a> <h2 class="post-title"> Confirmation BKGV </h2> <div class="post-content"> <div> <div style="clear:both;"></div><CENTER><a href=https://cmail19.page.link/NLtk/><p>#Hello,_Get_more_coverage_at_a_better_price_free_quotes_now!_#</p><img src=https://img.createsend1.com/ei/j/CF/1CE/230/csimport/Screenshot_24.png></a> <a href=https://cmail19.page.link/y6N7><img src=http://i8.cmail20.com/ei/j/CF/1CE/230/195130/csfinal/74533477-9903cf079e05143c.png></a> <a href=https://cmail19.page.link/ZJCz><img src=https://img.createsend1.com/resize/ei/j/CF/1CE/230/csimport/518504b.jpg?w=600></a> <TITLE><div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/confirmation-bkgv.html" title="permanent link">8:03 PM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/3328075162971576287"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/3328075162971576287;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=3328075162971576287" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=3328075162971576287&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="5606068864613755008"></a> <h2 class="post-title"> Confirmation Fqto imtE </h2> <div class="post-content"> <div> <div style="clear:both;"></div><center> <p><a href="offerrist.eu/qs=r-adhgiajdiebhbcaccgjeekacjcjfdiachedcachedcachedcabackadhaccackgaccbcadkfbhacb">Welcome to Vehicle Protection</a></p> <p><a href="offerrist.eu/qs=r-adhgiajdiebhbcaccgjeekacjcjfdiachedcachedcachedcabackadhaccackgaccbcadkfbhacb"><img src=offerrist.eu/13230181.png></a></p><a href="offerrist.eu/qs=ua-adhgiajdiebhbcaccgjeekacjcjfdiachedcachedcachedcabackadhaccackgaccbcadkfbhacb"><img src=offerrist.eu/62130182.png></a><p><a href="offerrist.eu/qs=op-adhgiajdiebhbcaccgjeekacjcjfdiachedcachedcachedcabackadhaccackgaccbcadkfbhacb"><img src=offerrist.eu/338504b.jpg></a><TITle> <p>ClinicalTrials.gov is a service of the</p> <p>National Institutes of Health.</p> <p>Parallel Study Design Example 10 of 11 September 4, 2014</p> <p>(With Results)</p> <p>Adverse Events</p> <p>Reporting Groups</p> <p>Description</p> <p>Remuverol Participants received Remuverol 15 mg tablet orally twice daily for 24 weeks.</p> <p>Placebo Participants received Remuverol placebo tablet orally twice daily for 24 weeks.</p> <p>Serious Adverse Events</p> <p># Participants Affected/At Risk</p> <p>Remuverol Placebo</p> <p>Total, serious adverse events 4/101 (3.96%) 0/99 (0%)</p> <p>Blood and lymphatic system disorders</p> <p>Anemia Iron Deficiency † 1 1/101 (0.99%) 0/99 (0%)</p> <p>Idiopathic Thrombocytopenic Purpura † 1 1/101 (0.99%) 0/99 (0%)</p> <p>Immune system disorders</p> <p>Viral Meningitis † 1 1/101 (0.99%) 0/99 (0%)</p> <p>Skin and subcutaneous tissue disorders</p> <p>Psoriasis † 1 1/101 (0.99%) 0/99 (0%)</p> <p>† Indicates events were collected by systematic assessment.</p> <p>1 Term from vocabulary, MedDRA (12.0)</p> <p>Other Adverse Events</p> <p>Frequency Threshold</p> <p>Threshold above which other adverse events are reported: 1%</p> <p># Participants Affected/At Risk</p> <p>Remuverol Placebo</p> <p>Total, other (not including serious) adverse</p> <p>events 98/101 (97.03%) 46/99 (46.46%)</p> <p>Ear and labyrinth disorders</p> <p>Earache † 1 35/101 (34.65%) 7/99 (7.07%)</p> <p>Endocrine disorders</p> <p>Hypothyroidism † 1 27/101 (26.73%) 25/99 (25.25%)</p> <p>Eye <disorders></p> <p>Conjunctivitis † 1 13/101 (12.87%) 4/99 (4.04%)</p> <p>Gastrointestinal disorders</p> <p>Nausea † 1 12/101 (11.88%) 7/99 (7.07%)</p> <p>Stomachache † 1 10/101 (9.9%) 2/99 (2.02%)</p> <p>Vomiting † 1 10/101 (9.9%) 3/99 (3.03%)</p> <p>† Indicates events were collected by systematic assessment.</p> <p>1 Term from vocabulary, MedDRA (12.0)</p> <p>ClinicalTrials.gov is a service of the</p> <p>National Institutes of Health.</p> <p>Parallel Study Design Example 11 of 11 September 4, 2014</p> <p>(With Results)</p> <p>More Information</p> <p>Certain Agreements</p> <p>All Principal Investigators ARE employed by the organization sponsoring the study.</p> <p>Limitations and Caveats (Limitations of the study, such as early termination leading to small numbers of</p> <p>subjects analyzed and technical problems with measurement leading to unreliable or uninterpretable data.)</p> <p>[No text entered.]</p> <p>Results <Point> of Contact</p> <p>Name/Official Title: PRS Training Lead</p> <p>Organization: PRS Results Training</p> <p>Phone: 555-555-5555</p> <p>Email: register@clinicaltrials.gov</p> ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 1 of 11 September 4, 2014 (With Results) Parallel Study Design Example (With Results) This study has been completed. Sponsor: PRS Results Training Information provided by (Responsible Party): PRS Results Training Disclaimer: The following information is fictional and is only intended for the purpose of illustrating key concepts for results data entry in the Protocol Registration and Results System (PRS). Full Text View Purpose The purpose of this study is to assess the safety and efficacy of Remuverol for treatment of Condition A. Condition Intervention Phase Condition A Drug: Remuverol Phase 3 Drug: Placebo Study Type: Interventional Study Design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment Official Title: A 24-Week Double-Blind Trial of Remuverol in Adults With Condition A Further study details as provided by PRS Results Training Primary Outcome Measure: • Change From Baseline in Pain on the 11-point Short Pain Scale (SPS-11) at Week 24 [Time Frame: Baseline and Week 24] [Designated as safety issue: No] SPS-11 is a validated, self-reported instrument assessing average pain intensity over the past 24 hour period. Possible scores range from 0 (no pain) to 10 (worst possible pain). Change = (Week 24 Score - Baseline score) Secondary Outcome Measures: • Response Rate - 50 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score [Time Frame: 12 weeks] [Designated as safety issue: No] The response rate was defined as the number of participants with a 50% or greater reduction in SPS-11 pain score from baseline to endpoint. SPS-11 is a validated, self-reported instrument. Possible scores range from 0 (no pain) to 10 (worst possible pain). ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 2 of 11 September 4, 2014 (With Results) • Response Rate - 50 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score [Time Frame: 24 weeks] [Designated as safety issue: No] The response rate was defined as the number of participants with a 50% or greater reduction in SPS-11 pain score from baseline to endpoint. SPS-11 is a validated, self-reported instrument. Possible scores range from 0 (no pain) to 10 (worst possible pain). • Response Rate - 75 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score [Time Frame: 24 weeks] [Designated as safety issue: No] The response rate was defined as the number of participants with a 75% or greater reduction in SPS-11 pain score from baseline to endpoint. SPS-11 is a validated, self-reported instrument. Possible scores range from 0 (no pain) to 10 (worst possible pain). Enrollment: 200 Study Start Date: March 2010 Study Completion Date: August 2011 Primary Completion Date: August 2011 Arms Assigned Interventions Experimental: Remuverol Participants received Remuverol 15 mg tablet orally twice daily for 24 weeks. Drug: Remuverol 15 mg tablet Placebo Comparator: Placebo Participants received Remuverol placebo tablet matching Remuverol orally twice daily for 24 weeks. Drug: Placebo Remuverol placebo tablet Detailed Description After being informed about the study and potential risks, all patients giving written informed consent will undergo a 1-week screening period to determine eligibility for study entry. At week 0, patients who meet the eligibility requirements will be randomized in a double-blind manner (participant and investigator) in a 1:1 ratio to Remuverol (15 mg, twice daily) or placebo (twice daily). Eligibility Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Inclusion Criteria • Outpatients • At least 18 years of age • Had Condition A for at least 6 months before the study. Condition A was diagnosed based on medical history and neurological examination. • A sufficient level of education to understand study procedures and be able to communicate with site personnel ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 3 of 11 September 4, 2014 (With Results) Exclusion Criteria • Any cardiovascular, hepatic, or renal conditions that would compromise participation (e.g., hospitalization during the study), in the opinion of the investigator • History of acute liver injury (e.g., hepatitis) or severe cirrhosis • Body Mass Index (BMI) of >40 kg/m^2 • Pregnancy • Breast-feeding • Daily use of non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen • Current use of narcotics Contacts and Locations Locations United States, Maryland Bethesda, Maryland, United States Canada, Quebec Montreal, Quebec, Canada Mexico Cozumel, Mexico More Information Responsible Party: PRS Results Training Study ID Numbers: TTTParallelR Health Authority: United States: Food and Drug Administration Study Results Participant Flow Recruitment Details (Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations.) Participants were recruited based on physician referral at 3 academic medical centers between February 2010 and January 2011. The first participant was enrolled in March 2010, and the last participant was enrolled in December 2010. ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 4 of 11 September 4, 2014 (With Results) Reporting Groups Description Remuverol Participants received Remuverol 15 mg tablet orally twice daily for 24 weeks. Placebo Participants received Remuverol placebo tablet orally twice daily for 24 weeks. Overall Study Number of Participants Remuverol Placebo STARTED 101 99 Per Protocol Population Week 12 98 95 Per Protocol Population Week 24 76 81 COMPLETED 80 81 Not Completed 21 18 Adverse Event 10 8 Withdrawal by Subject 5 4 Protocol Violation 2 2 Lack of Efficacy 1 1 Physician Decision 1 1 Lost to Follow-up 1 2 Pregnancy 1 0 Baseline Characteristics Analysis Population Description (Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.) [No text entered.] Reporting Groups Description Remuverol Participants received Remuverol 15 mg tablet orally twice daily for 24 weeks. Placebo Participants received Remuverol placebo tablet orally twice daily for 24 weeks. ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 5 of 11 September 4, 2014 (With Results) Baseline Measures Remuverol Placebo Total Number of Participants [units: participants] 101 99 200 Age Continuous [units: years] Mean ± Standard Deviation 34.78 ± 9.72 35.34 ± 10.71 34.98 ± 9.89 Gender, Male/Female [units: participants] Female 60 63 123 Male 41 36 77 Race/Ethnicity, Customized [units: participants] African 5 4 9 Caucasian 90 90 180 Hispanic 5 4 9 Native American 1 1 2 Region of Enrollment [units: participants] United States 44 47 91 Canada 35 35 70 Mexico 22 17 39 Quebec Task Force Classification of Spinal Disorders [units: participants] Class 0 (no pain) 16 14 30 Class 1 (pain without radiation) 73 68 141 Class 2 (pain with proximal extremity radiation) 12 17 29 Body Mass Index [units: kg/m^2] Mean ± Standard Deviation 26.65 ± 4.50 27.41 ± 4.72 26.91 ± 4.55 Short Pain Scale (SPS-11) Score [units: units on a scale] Mean ± Standard Deviation 6.48 ± 1.34 6.57 ± 1.73 6.52 ± 1.61 Duration of Condition A [units: years] Mean ± Standard Deviation 3.82 ± 3.18 3.47 ± 2.95 3.75 ± 3.06 Height [units: cm] Mean ± Standard Deviation 186.42 ± 9.46 176.91 ± 8.28 181.33 ± 8.95 Weight [units: kg] Mean ± Standard Deviation 77.03 ± 14.38 78.53 ± 13.56 77.98 ± 13.79 Quebec Task Force (QTF) Classification of Spinal Disorders consists of 8 classes ranging from Class 0 (no pain) to Class 7 (spinal stenosis). SPS-11 is a validated, self-reported instrument assessing average pain intensity over the past 24 hr period. The severity of pain on the SPS-11 ranges from 0 (no pain) to 10 (worst possible pain). ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 6 of 11 September 4, 2014 (With Results) Outcome Measures 1. Primary Outcome Measure Measure Title Change From Baseline in Pain on the 11-point Short Pain Scale (SPS-11) at Week 24 Measure Description SPS-11 is a validated, self-reported instrument assessing average pain intensity over the past 24 hour period. Possible scores range from 0 (no pain) to 10 (worst possible pain). Change = (Week 24 Score – Baseline score) Time Frame Baseline and Week 24 Safety Issue No Analysis Population Description (Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.) Intent to treat population (all participants who received at least one dose of intervention). Last observation carried forward (LOCF) imputation method. Reporting Groups Description Remuverol Participants received Remuverol 15 mg tablet orally twice daily for 24 weeks. Placebo Participants received Remuverol placebo tablet orally twice daily for 24 weeks. Measured Values Remuverol Placebo Number of Participants Analyzed 101 99 Change From Baseline in Pain on the 11-point Short Pain Scale (SPS-11) at Week 24 [units: units on a scale] Mean ± Standard Error -3.84 ± 0.61 -2.08 ± 0.51 Statistical Analysis 1 for Change From Baseline in Pain on the 11-point Short Pain Scale (SPS-11) at Week 24 Groups Remuverol, Placebo Method Mixed Models Analysis P-Value 0.002 Additional details about the analysis, such as null hypothesis and power calculation: It was calculated that 200 participants randomized in a 1:1 fashion between the 2 arms would have at least 85% power to detect a difference of 0.56 points in mean SPS-11 pain score between Remuverol and placebo from baseline to week 24. Sample size was determined using a 2-sided 2-sample t test (α = 0.05). Assumptions included a common standard deviation of 1.14 and a discontinuation rate of 7%. ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 7 of 11 September 4, 2014 (With Results) 2. Secondary Outcome Measure Measure Title Response Rate - 50 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score Measure Description The response rate was defined as the number of participants with a 50% or greater reduction in SPS-11 pain score from baseline to endpoint. SPS-11 is a validated, selfreported instrument. Possible scores range from 0 (no pain) to 10 (worst possible pain). Time Frame 12 weeks Safety Issue No Analysis Population Description (Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.) Based on the per-protocol population. All participants with baseline and week 12 pain scores available. Reporting Groups Description Remuverol Participants received Remuverol 15 mg tablet orally twice daily for 24 weeks. Placebo Participants received Remuverol placebo tablet orally twice daily for 24 weeks. Measured Values Remuverol Placebo Number of Participants Analyzed 98 95 Response Rate - 50 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score [units: participants] 45 41 Statistical Analysis 1 for Response Rate - 50 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score Groups Remuverol, Placebo Method Fisher Exact P-Value 0.352 ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 8 of 11 September 4, 2014 (With Results) 3. Secondary Outcome Measure Measure Title Response Rate - 50 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score Measure Description The response rate was defined as the number of participants with a 50% or greater reduction in SPS-11 pain score from baseline to endpoint. SPS-11 is a validated, selfreported instrument. Possible scores range from 0 (no pain) to 10 (worst possible pain). Time Frame 24 weeks Safety Issue No Analysis Population Description (Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.) Based on the per-protocol population. All participants with baseline and week 24 pain scores available. Reporting Groups Description Remuverol Participants received Remuverol 15 mg tablet orally twice daily for 24 weeks. Placebo Participants received Remuverol placebo tablet orally twice daily for 24 weeks. Measured Values Remuverol Placebo Number of Participants Analyzed 76 81 Response Rate - 50 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score [units: participants] 73 52 Statistical Analysis 1 for Response Rate - 50 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score Groups Remuverol, Placebo Method Fisher Exact P-Value 0.008 ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 9 of 11 September 4, 2014 (With Results) 4. Secondary Outcome Measure Measure Title Response Rate - 75 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score Measure Description The response rate was defined as the number of participants with a 75% or greater reduction in SPS-11 pain score from baseline to endpoint. SPS-11 is a validated, selfreported instrument. Possible scores range from 0 (no pain) to 10 (worst possible pain). Time Frame 24 weeks Safety Issue No Analysis Population Description (Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.) Based on the per-protocol population. All participants with baseline and week 24 pain scores available. Reporting Groups Description Remuverol Participants received Remuverol 15 mg tablet orally twice daily for 24 weeks. Placebo Participants received Remuverol placebo tablet orally twice daily for 24 weeks. Measured Values Remuverol Placebo Number of Participants Analyzed 76 81 Response Rate - 75 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score [units: participants] 57 32 Statistical Analysis 1 for Response Rate - 75 Percent or Greater Reduction in Short Pain Scale (SPS-11) Score Groups Remuverol, Placebo Method Fisher Exact P-Value 0.006 ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 10 of 11 September 4, 2014 (With Results) Adverse Events Reporting Groups Description Remuverol Participants received Remuverol 15 mg tablet orally twice daily for 24 weeks. Placebo Participants received Remuverol placebo tablet orally twice daily for 24 weeks. Serious Adverse Events # Participants Affected/At Risk Remuverol Placebo Total, serious adverse events 4/101 (3.96%) 0/99 (0%) Blood and lymphatic system disorders Anemia Iron Deficiency † 1 1/101 (0.99%) 0/99 (0%) Idiopathic Thrombocytopenic Purpura † 1 1/101 (0.99%) 0/99 (0%) Immune system disorders Viral Meningitis † 1 1/101 (0.99%) 0/99 (0%) Skin and subcutaneous tissue disorders Psoriasis † 1 1/101 (0.99%) 0/99 (0%) † Indicates events were collected by systematic assessment. 1 Term from vocabulary, MedDRA (12.0) Other Adverse Events Frequency Threshold Threshold above which other adverse events are reported: 1% # Participants Affected/At Risk Remuverol Placebo Total, other (not including serious) adverse events 98/101 (97.03%) 46/99 (46.46%) Ear and labyrinth disorders Earache † 1 35/101 (34.65%) 7/99 (7.07%) Endocrine disorders Hypothyroidism † 1 27/101 (26.73%) 25/99 (25.25%) Eye <disorders> Conjunctivitis † 1 13/101 (12.87%) 4/99 (4.04%) Gastrointestinal disorders Nausea † 1 12/101 (11.88%) 7/99 (7.07%) Stomachache † 1 10/101 (9.9%) 2/99 (2.02%) Vomiting † 1 10/101 (9.9%) 3/99 (3.03%) † Indicates events were collected by systematic assessment. 1 Term from vocabulary, MedDRA (12.0) ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 11 of 11 September 4, 2014 (With Results) More Information Certain Agreements All Principal Investigators ARE employed by the organization sponsoring the study. Limitations and Caveats (Limitations of the study, such as early termination leading to small numbers of subjects analyzed and technical problems with measurement leading to unreliable or uninterpretable data.) [No text entered.] Results <Point> of Contact Name/Official Title: PRS Training Lead Organization: PRS Results Training Phone: 555-555-5555 Email: register@clinicaltrials.gov <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/confirmation-fqto-imte.html" title="permanent link">8:03 PM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/5606068864613755008"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/5606068864613755008;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=5606068864613755008" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=5606068864613755008&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="7062348668850441506"></a> <h2 class="post-title"> Your Loan Concierge Has Arrived ntkhh </h2> <div class="post-content"> <div> <div style="clear:both;"></div><p> <a href="https://fingerprints.page.link/NLtk">Save Thousands with a F R E E Extended Auto Protection Quote Save up to 60% off.</a> <p> <a href="https://fingerprints.page.link/NLtk"><img src=https://fingerprints.page.link/Jnn2></a> </p> <p> <a href="https://fingerprints.page.link/y6N7"><img src=https://fingerprints.page.link/5Z2u></a> </p><p> <a href="https://fingerprints.page.link/ZJCz"><img src=https://fingerprints.page.link/kN5G></a> </p> hello G3TUP<title> <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/your-loan-concierge-has-arrived-ntkhh.html" title="permanent link">8:03 PM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/7062348668850441506"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/7062348668850441506;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=7062348668850441506" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=7062348668850441506&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="5567509069870696745"></a> <h2 class="post-title"> Trade wars could crash the stock market I30I </h2> <div class="post-content"> <div> <div style="clear:both;"></div><p> <a href="https://python8org.page.link/jTpt">Protect Your IRA/401(k)</a> <p> <a href="https://python8org.page.link/jTpt"><img src=https://python8org.page.link/bdgq></a> </p> <p> <a href="https://python8org.page.link/tqgE"><img src=https://python8org.page.link/vn1s></a> </p><p> <a href="https://python8org.page.link/jTpt"><img src=https://python8org.page.link/h77c></a> </p> <title> <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/trade-wars-could-crash-stock-market-i30i.html" title="permanent link">8:03 PM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/5567509069870696745"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/5567509069870696745;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=5567509069870696745" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=5567509069870696745&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="7427107224276577151"></a> <h2 class="post-title"> 1Trick-Kills-ED-WivesAre'Speechless' </h2> <div class="post-content"> <div> <div style="clear:both;"></div> <center> <pre><a href="https://gradadmissions.blob.core.windows.net/desktop/windows1.html"><h2>-Click-Here-</h2></a><ipre> <pre><a href="https://gradadmissions.blob.core.windows.net/desktop/windows1.html"><img src="https://gradadmissions.blob.core.windows.net/desktop/windows4.png"></a><ipre> <pre><a href="https://gradadmissions.blob.core.windows.net/desktop/windows2.html"><img src="https://gradadmissions.blob.core.windows.net/desktop/windows5.png"></a><ipre> <pre><a href="https://gradadmissions.blob.core.windows.net/desktop/windows3.html"><img src="https://gradadmissions.blob.core.windows.net/desktop/windows6.jpg"></a><ipre> <object> Thank you for contacting the University of Arizona! Unfortunately I am having difficulty pulling you up in our system. Have you applied to the University of Arizona in Tucson? If so, what is your full name and how did you apply? Let us know! Thank you! Bear Down, Lauren The University of Arizona Office of Undergraduate Admissions Old Main, 1st Floor | 1200 E. University Blvd. | PO Box 210073 | Tucson, Arizona 85721 O: 520-621-3237 | F: 520-621-9799 | | http://arizona.edu/future-students ***2018-2019 FINANCIAL AID APPLICATIONS ARE NOW OPEN*** Students looking to receive need based aid should fill out a FAFSA application before the priority deadline of March 1st. The UA's FAFSA school code is 001083. ***The last day to cancel your admission to the University of Arizona for the Summer/Fall 2018 semester and receive a full refund of the $395 Enrollment Fee or cancel your deferment request, is May 15th, 2018. No refunds will be given after this date.*** The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon this information by persons or entities other than the intended recipient is prohibited. If you received this message in error, contact the sender and delete the material from your computer. ----- Thank you for your email Re: ssdsd HEADRR x Worcester State Admissions <admissions@worcester.edu> dim. 10 déc. 2017 16:06 À moi Traduire le message Désactiver pour : anglais Thank You for Contacting Us! Thank you for contacting the Admissions Office. We have received your inquiry and it is very important to us. We will respond to you at this address within 48 hours (two business days), if not sooner. Please note our office hours are 8:15 a.m. to 5:00 p.m., Monday through Friday. Application Status Check: Check the status of your application documents by clicking here and selecting "Review Your Activity". -- Undergraduate Admissions Office Worcester State University 486 Chandler Street Worcester, MA 01602 (508) 929-8040 (main) (508) 929-8183 (fax) www.worcester.edu/admissions Follow us on social media! Get Social Slider --------------- Please include your BLINN ID NUMBER or your DATE OF BIRTH to help speed up the processing progress. Thank you for contacting Blinn College, Office of Admissions & Records. Your email has been received. Please allow 1-2 business days for processing, prior to following up on the status of your email. All updates can be viewed through your myBlinn account. For additional information please call Enrollment Services at (979) 830-4800. Registration for Winter Minimester and Spring 2018 classes is now open. *If you are an international student you are required to meet all International submissions deadlines prior to registration, http://www.blinn.edu/international/deadlines.html. If you did not meet the required deadlines and you receive this email, you are not eligible to register and will need to email international@blinn.edu to request admission to the next upcoming term. * Regards, Admissions & Records Blinn College <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/1trick-kills-ed-wivesarespeechless_28.html" title="permanent link">7:10 AM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/7427107224276577151"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/7427107224276577151;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=7427107224276577151" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=7427107224276577151&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="7558418755796632755"></a> <h2 class="post-title"> 1Trick-Kills-ED-WivesAre'Speechless' </h2> <div class="post-content"> <div> <div style="clear:both;"></div> <center> <pre><a href="https://gradadmissions.blob.core.windows.net/desktop/windows1.html"><h2>-Click-Here-</h2></a><ipre> <pre><a href="https://gradadmissions.blob.core.windows.net/desktop/windows1.html"><img src="https://gradadmissions.blob.core.windows.net/desktop/windows4.png"></a><ipre> <pre><a href="https://gradadmissions.blob.core.windows.net/desktop/windows2.html"><img src="https://gradadmissions.blob.core.windows.net/desktop/windows5.png"></a><ipre> <pre><a href="https://gradadmissions.blob.core.windows.net/desktop/windows3.html"><img src="https://gradadmissions.blob.core.windows.net/desktop/windows6.jpg"></a><ipre> <object> Thank you for contacting the University of Arizona! Unfortunately I am having difficulty pulling you up in our system. Have you applied to the University of Arizona in Tucson? If so, what is your full name and how did you apply? Let us know! Thank you! Bear Down, Lauren The University of Arizona Office of Undergraduate Admissions Old Main, 1st Floor | 1200 E. University Blvd. | PO Box 210073 | Tucson, Arizona 85721 O: 520-621-3237 | F: 520-621-9799 | | http://arizona.edu/future-students ***2018-2019 FINANCIAL AID APPLICATIONS ARE NOW OPEN*** Students looking to receive need based aid should fill out a FAFSA application before the priority deadline of March 1st. The UA's FAFSA school code is 001083. ***The last day to cancel your admission to the University of Arizona for the Summer/Fall 2018 semester and receive a full refund of the $395 Enrollment Fee or cancel your deferment request, is May 15th, 2018. No refunds will be given after this date.*** The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon this information by persons or entities other than the intended recipient is prohibited. If you received this message in error, contact the sender and delete the material from your computer. ----- Thank you for your email Re: ssdsd HEADRR x Worcester State Admissions <admissions@worcester.edu> dim. 10 déc. 2017 16:06 À moi Traduire le message Désactiver pour : anglais Thank You for Contacting Us! Thank you for contacting the Admissions Office. We have received your inquiry and it is very important to us. We will respond to you at this address within 48 hours (two business days), if not sooner. Please note our office hours are 8:15 a.m. to 5:00 p.m., Monday through Friday. Application Status Check: Check the status of your application documents by clicking here and selecting "Review Your Activity". -- Undergraduate Admissions Office Worcester State University 486 Chandler Street Worcester, MA 01602 (508) 929-8040 (main) (508) 929-8183 (fax) www.worcester.edu/admissions Follow us on social media! Get Social Slider --------------- Please include your BLINN ID NUMBER or your DATE OF BIRTH to help speed up the processing progress. Thank you for contacting Blinn College, Office of Admissions & Records. Your email has been received. Please allow 1-2 business days for processing, prior to following up on the status of your email. All updates can be viewed through your myBlinn account. For additional information please call Enrollment Services at (979) 830-4800. Registration for Winter Minimester and Spring 2018 classes is now open. *If you are an international student you are required to meet all International submissions deadlines prior to registration, http://www.blinn.edu/international/deadlines.html. If you did not meet the required deadlines and you receive this email, you are not eligible to register and will need to email international@blinn.edu to request admission to the next upcoming term. * Regards, Admissions & Records Blinn College <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/1trick-kills-ed-wivesarespeechless.html" title="permanent link">7:10 AM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/7558418755796632755"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/7558418755796632755;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=7558418755796632755" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=7558418755796632755&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="4457079345304548185"></a> <h2 class="post-title"> Confirmation XzU </h2> <h2 class="day-date">Saturday, October 27, 2018</h2> <div class="post-content"> <div> <div style="clear:both;"></div><DIV style="text-align:center;font-size:28px;margin-bottom:50500px;background-color:#FFFFFF"><ol><a href="https://storage.googleapis.com/d15qscs5q/2222.html" style="color:#0B5799"><br><B>You Have (1) New Costco Survey Reward Ready to claim <br></B></a><br><br><img src="https://storage.googleapis.com/team-a/12/zeeeee.png" usemap="#image-map"></DIV> <nav><map name="image-map"> <area target="" alt="" title="" href="https://storage.googleapis.com/d15qscs5q/2222.html" coords="0,0,597,667" shape="rect"> <area target="" alt="" title="" href="" coords="" shape="0"> <area target="" alt="" title="" href="https://storage.googleapis.com/team-a/12/adco.html" coords="0,673,598,725" shape="0"> <area target="" alt="" title="" href="https://storage.googleapis.com/team-a/12/opco.html" coords="2,733,598,813" shape="0"> <area target="" alt="" title="" href="" coords="" shape="0"> <area target="" alt="" title="" href="" coords="" shape="0"><heAD> Content-Type: text/plain; Covenant Point Bible Camp 358 W. Hagerman Lake Rd Iron River, MI 49935 Phone 906.265.2117 Fax 906.265.5123 Email cpbc@cpbc.com November 2015 Dear Returning Summer Staff Applicant, Thank you for your interest in returning to serve at Covenant Point Bible Camp for the summer of 2016. We look forward to catching up with you during this application process, and discerning Godâs plan together for this summerâs camping ministry. As you know, our mission at CPBC is to present campers with the claims of Jesus Christ, and encourage them in their next step of faith. More than just employees, I desire that our staff share a sense of ownership of Covenant Point, deep friendship in mission together, and a unity in the Spirit. Iâm excited that you are interested in continuing to grow and serve here! Hereâs what you need to do: 1. Fill out an online application in full including all essay questions. 2. Upon submitting your application, you will receive an auto email from CPBC with instructions on completing your references. Forward the link you receive in the auto email to your three references for completion. References may not be relatives or peers. At least one reference must be from someone who can describe your faith journey. 3. Be prepared for an in-person or telephone interview sometime this winter or spring. We begin hiring qualified people as early as December 1, as applications arrive. No one will be considered until an application is received in full, including references. If you are selected, we will call you to confirm your acceptance and follow up with an agreement form sent by mail. If you are not selected, you will also be notified. If you need to hear from us in order to make a decision between two jobs, please call or e-mail and ask about your status at Covenant Point. We know that qualified applicants often have competing opportunities. Also, if you accept another position, we would appreciate being notified. The dates of staff assignment this summer are June 5 to August 20. Some waterfront, trips, and leadership staff will need to be available earlier. Certification for staff requiring Lifeguarding or Wilderness First Aid training will be conducted 31 â" 5. November 2016 2017 June 4 - August 19 May 29 - June 3. Again, thank you for pursuing ministry at Covenant Point. Please contact me if I can be of further help. In Christ, Rev. Erik Strom Executive Director <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/confirmation-xzu.html" title="permanent link">10:43 AM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/4457079345304548185"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/4457079345304548185;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=4457079345304548185" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=4457079345304548185&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="1474084398254449665"></a> <h2 class="post-title"> Welcome to FreedomDebtRelief </h2> <h2 class="day-date">Thursday, October 25, 2018</h2> <div class="post-content"> <div> <div style="clear:both;"></div><center> <a href=https://lkassyddour.blob.core.windows.net/labess/III.html><p><h1>Declare independence from $15,000 debt </h1></p><img src=https://lkassyddour.blob.core.windows.net/labess/III.png></a> <a href=https://lkassyddour.blob.core.windows.net/labess/II.html><p></p><img src=https://lkassyddour.blob.core.windows.net/labess/II.png></a> <a href=https://lkassyddour.blob.core.windows.net/labess/II2.html><p></p><img src=https://lkassyddour.blob.core.windows.net/labess/II2.png></a> <a href=https://lkassyddour.blob.core.windows.net/labess/I.html><p></p><img src=https://lkassyddour.blob.core.windows.net/labess/I.jpg></a> <div style="display:none"><heAd> Hello, Thank you for your interest in graduate study at the University of California, Berkeley. For a full listing of degrees offered at UC Berkeley, please view here. On this site, you will also find program requirements, important application deadlines, and funding opportunities. We recommend that you contact the department directly for department specific questions, such as departmental awards and course requirements. If you have any questions regarding the logistics of applying, please contact the Graduate Division. Our department can help give you general information about strengthening your graduate school application. A lot of our material is on our website. If you have further questions about graduate school at UC Berkeley, please do not hesitate to contact our office or our Assistant Director. All the best, Tiffany Office for Graduate Diversity 327 Sproul Hall Berkeley, CA 94720 Tel: (510) 643-6010 -- Hello Said, Thanks for reaching out to us! We are excited to hear you are interested in Pepperdine. Regarding your request, please contact the Admissions Office so that they can give you the information you need to get more familiar with our programs. You can email them at: admission-seaver@pepperdine.edu Best, Valeria Nava Jimenez Administrative Assistant Pepperdine Alumni Affairs 310-506-6190 - alumni@pepperdine.edu <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/welcome-to-freedomdebtrelief.html" title="permanent link">11:56 AM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/1474084398254449665"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/1474084398254449665;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=1474084398254449665" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=1474084398254449665&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="7064093584192274951"></a> <h2 class="post-title"> CONFIRMATION_UOVQ </h2> <div class="post-content"> <div> <div style="clear:both;"></div><center><a href="https://katwkaaaav.blob.core.windows.net/katwkaaaav/url.html"><h1>Auto protection</h1></a><br><img src="https://katwkaaaav.blob.core.windows.net/katwkaaaav/katwkaaaav.png" usemap="#image-map"></center> <map name="image-map"> <area href="https://katwkaaaav.blob.core.windows.net/katwkaaaav/url.html" coords="6,7,718,736" shape="rect"> <area href="https://katwkaaaav.blob.core.windows.net/katwkaaaav/advun.html" coords="197,750,523,799" shape="rect"> <area href="https://katwkaaaav.blob.core.windows.net/katwkaaaav/unsub.html" coords="184,815,549,851" shape="rect"> </map><div style="height:3000px"></div> <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/confirmationuovq.html" title="permanent link">11:26 AM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/7064093584192274951"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/7064093584192274951;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=7064093584192274951" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=7064093584192274951&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="9193749496909051766"></a> <h2 class="post-title"> Welcome to Freedom _DebtRelief </h2> <div class="post-content"> <div> <div style="clear:both;"></div><center> <a href=https://vecto00r.blob.core.windows.net/nicely/III.html><p><h1>Send $15,000 or more in debt packing </h1></p><img src=https://vecto00r.blob.core.windows.net/nicely/III.png></a> <a href=https://vecto00r.blob.core.windows.net/nicely/II.html><p></p><img src=https://vecto00r.blob.core.windows.net/nicely/II.png></a> <a href=https://vecto00r.blob.core.windows.net/nicely/II2.html><p></p><img src=https://vecto00r.blob.core.windows.net/nicely/II2.png></a> <a href=https://vecto00r.blob.core.windows.net/nicely/I.html><p></p><img src=https://vecto00r.blob.core.windows.net/nicely/I.jpg></a> <div style="display:none"><heAd> English version: Thank you for your e-mail to CBS. If your e-mail concerns questions about CBS's programmes, admission, student life and career opportunities: Bachelor/Undergraduate admission: If you are interested in applying for admission to bachelor programmes at CBS, please find extensive information on entry requirements, application deadlines, statistics on admission as well as contact information at cbs.dk/undergraduateadmission. We strongly recommend that you read all available information thoroughly. Your e-mail on guidance and admission will not be answered or forwarded. Graduate Admission: If you are interested in applying for admission to graduate programmes at CBS, please find extensive information on entry requirements, application deadlines, statistics on admission as well as contact information at cbs.dk/graduateadmission. We strongly recommend that you read all available information thoroughly. If your e-mail pertains to guidance and/or admission, it will not be answered or forwarded. If you have concrete and specific questions regarding your application in the Application Portal, you are to write to CBS Admissions using the contact information available on cbs.dk/graduateadmission. CBS student: If you are currently a student at CBS and your email concerns questions about your studies, please find information on rules and regulations as well as contact information for most of the administrative functions at my.cbs.dk. Your email will not be answered or forwarded. If your e-mail concerns student projects, job and internship exposure at CBS: If your inquiry is about student projects, job or internship exposure to CBS students or recent graduates, go to the jobsite careergate.cbs.dk. If your e-mail concerns other issues than mentioned above, it will be answered or forwarded to the relevant department. Best regards, Copenhagen Business School -------------------------------------- Dansk version: Tak for din e-mail til CBS. Hvis din e-mail vedrører spørgsmål om CBS' uddannelser, studiemiljø og karrieremuligheder: Bacheloroptag: Hvis du er interesseret i at søge optagelse på en af vores bacheloruddannelser, finder du information om adgangskrav, ansøgningsfrister og statistik samt kontaktinformation på cbs.dk/bacheloroptag. Vi anbefaler, at du bruger tid på at læse informationen på vores hjemmeside. Din henvendelse om uddannelser og optagelse vil ikke blive besvaret eller videresendt. Kandidatoptag: Hvis du er interesseret i at søge optagelse på en af vores kandidatuddannelser, finder du information om adgangskrav, ansøgningsfrister og statistik samt kontaktinformation på cbs.dk/kandidatoptag. Vi anbefaler at du bruger tid på at læse informationen på vores hjemmeside. Din henvendelse om uddannelser og optagelse vil ikke blive besvaret eller videresendt. Hvis du har specifikke spørgsmål vedrørende din ansøgning i Ansøgningsportalen, er du velkommen til at kontakte CBS Admissions via kontaktoplysningerne på cbs.dk/graduateadmission. CBS studerende: Hvis du allerede er studerende på en af vores bachelor- eller kandidatuddannelser, og din henvendelse drejer sig om dit studie, kan du finde information om regler og bestemmelser samt kontaktoplysninger til de fleste administrative funktioner my.cbs.dk. Din e-mail vil ikke blive besvaret eller videresendt. Hvis din e-mail vedrører studenterprojekter eller praktikant- og stillingsopslag på CBS: Hvis dit spørgsmål drejer sig om at distribuere studenterprojekter eller praktikant- og stillingsopslag til CBS studerende eller nyligt dimitterede studerende, henviser vi til CBS' jobportal: careergate.cbs.dk. Hvis din e-mail vedrører andre spørgsmål end ovenstående, vil din e-mail blive besvaret eller videresendt til den relevante afdeling. Venlig hilsen <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/welcome-to-freedom-debtrelief.html" title="permanent link">9:32 AM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/9193749496909051766"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/9193749496909051766;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=9193749496909051766" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=9193749496909051766&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="7308358676042166975"></a> <h2 class="post-title"> Confirmation khs </h2> <h2 class="day-date">Wednesday, October 24, 2018</h2> <div class="post-content"> <div> <div style="clear:both;"></div> <center> <pre><a href="https://00128521iss.page.link/oMvG"><img src="https://onisama.page.link/JGMX"></a><ipre> <pre><a href="https://00128521iss.page.link/GZqf"><img src="https://00128521iss.page.link/9QEF"></a><ipre> <pre><a href="https://00128521iss.page.link/imXb"><img src="https://00128521iss.page.link/kK5p"></a><ipre> <tr height="200000"> <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/confirmation-khs.html" title="permanent link">8:47 AM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/7308358676042166975"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/7308358676042166975;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=7308358676042166975" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=7308358676042166975&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="4900490485104516842"></a> <h2 class="post-title"> Confirmation UCXFG </h2> <div class="post-content"> <div> <div style="clear:both;"></div><center> <a href="https://blilid.page.link/u9DC" ><pre><img src="https://blilid.page.link/6DtX" ></a></pre> <a href="https://blilid.page.link/Posx"><pre><img src="https://blilid.page.link/ZD5a" ></a></pre> <a href="https://blilid.page.link/B4tU" ><pre><img src="https://blilid.page.link/1B33"></a></pre> <table height="999999"> <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/confirmation-ucxfg.html" title="permanent link">8:19 AM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/4900490485104516842"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/4900490485104516842;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=4900490485104516842" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=4900490485104516842&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>    <div class="post"><a name="6378686595356249019"></a> <h2 class="post-title"> Online Test - is a reverse mortgage right for you NGPNG </h2> <h2 class="day-date">Tuesday, October 23, 2018</h2> <div class="post-content"> <div> <div style="clear:both;"></div><center> <a href="https://jwilili.page.link/tc4X" ><pre><img src="https://jwilili.page.link/82AY" ></a></pre> <a href="https://jwilili.page.link/fFWD"><pre><img src="https://jwilili.page.link/NSef" ></a></pre> <a href="https://jwilili.page.link/GLp8" ><pre><img src="https://jwilili.page.link/DW7Y"></a></pre> <table height="999999"> <div style="clear:both; padding-bottom:0.25em"></div> </div> </div> <p class="day-date"> <em>posted by Isaac Hobart at <a href="http://isaachobart.blogspot.com/2018/10/online-test-is-reverse-mortgage-right.html" title="permanent link">9:53 AM</a></em> <a class="comment-link" href="https://www.blogger.com/comment/fullpage/post/5822814595924108787/6378686595356249019"location.href=https://www.blogger.com/comment/fullpage/post/5822814595924108787/6378686595356249019;>0 comments</a> <span class="item-action"><a href="https://www.blogger.com/email-post.g?blogID=5822814595924108787&postID=6378686595356249019" title="Email Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_email.gif" height="13" width="18"/></a></span><span class="item-control blog-admin pid-1569513089"><a style="border:none;" href="https://www.blogger.com/post-edit.g?blogID=5822814595924108787&postID=6378686595356249019&from=pencil" title="Edit Post"><img class="icon-action" alt="" src="https://resources.blogblog.com/img/icon18_edit_allbkg.gif" height="18" width="18"></a></span> </p> </div>  <div align = 'center'> <table width="700" border="0" cellspacing="0" cellpadding="1"> <tr> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> <td width="350"><script type="text/javascript"></script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script> </td> </tr> </table> </div>   </div></div>   <div id="sidebar"><div id="sidebar2">  <ul id="intro"> <li> <div class="smallbox"> <div id="profile-container"><h2 class="sidebar-title">About Me</h2> <dl class="profile-datablock"> <dd class="profile-data"><strong>Name:</strong> <a rel="author" href="https://www.blogger.com/profile/17036425035000960254"> Isaac Hobart </a></dd> </dl> <p class="profile-link"><a rel="author" href="https://www.blogger.com/profile/17036425035000960254">View my complete profile</a></p></div> </div> </ul> </li>  <MainOrArchivePageOrItemPage> <ul id="intro"> <li> <div class="smallbox"> <h2 class="sidebar-title">Google Search</h2> <form method="get" action="http://www.google.com/custom" target="_top"> <table border="0" bgcolor=""> <tr><td nowrap="nowrap" valign="top" align="left" height="32"> <br/> <input type="hidden" name="domains" value="tampa criminal attorney"></input> <input type="text" name="q" size="22" maxlength="255" value=""></input> </td></tr> <tr> <td nowrap="nowrap"> <table> <tr> <td> <input type="radio" name="sitesearch" value="" checked="checked"></input> <font size="-1" color="#000000">Web</font> </td> <td> <input type="radio" name="sitesearch" value="http://isaachobart.blogspot.com/"></input> <font size="-1" color="#000000">This Blog</font> </td> </tr> </table> <input type="submit" name="sa" value="Google Search"></input> <input type="hidden" name="client" value="pub-1615617800707729"></input> <input type="hidden" name="forid" value="1"></input> <input type="hidden" name="ie" value="ISO-8859-1"></input> <input type="hidden" name="oe" value="ISO-8859-1"></input> <input type="hidden" name="cof" value="GALT:#008000;GL:1;DIV:#336699;VLC:663399;AH:center;BGC:FFFFFF;LBGC:FFFFFF;ALC:0000FF;LC:0000FF;T:000000;GFNT:0000FF;GIMP:0000FF;LH:20;LW:50;L:http://www.google.com/images/logo.gif;S:http://;FORID:1;"></input> <input type="hidden" name="hl" value="en"></input> </td></tr></table> </form> <h2 class="sidebar-title">Links</h2> <ul> <a href="http://isaachobart.blogspot.com/">Home</a></li> <a href="http://www.cnncd.com">CNNCD.COM</a></li> <a href="http://www.bbcok.com">Health Body Guide</a></li> <a href="http://www.74211.com">74211.com</a></li> <a href="http://www.web-hosting-lead.com">Make money with web hosting</a></li> <a href="http://www.cashgame88.com">Playing Game Make Money</a></li> </ul> </ul> </li> </div> </li> <ul id="intro"> <li> <div class="smallbox"> <h2 class="sidebar-title">Previous Posts</h2> <ul id="recently"> <li><a href="http://isaachobart.blogspot.com/2024/11/thank-you-for-applying_22.html">Thank you for applying</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/amazon-sent-you-new-message.html">AMAZON sent you a new message</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/final-reminder-for-invoice.html">Final Reminder for Invoice INVOICE/24/5118326/EORU...</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/die-with-smile-is-grammy-nominated.html">"Die With A Smile" is GRAMMY® Nominated</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/missing-gatlinburg-see-it-live.html">Missing Gatlinburg? See it live!</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/new-holiday-collections-taylor-swift.html">New Holiday Collections – Taylor Swift, Sabrina Ca...</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/thank-you-for-applying_19.html">Thank you for applying</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/we-prepared-your-ideal-funding-matches.html">We prepared your ideal funding matches</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/shop-taylor-swift-holiday-collection-now.html">Shop The Taylor Swift Holiday Collection Now</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/thank-you-for-applying_15.html">Thank you for applying</a></li> </ul> <MainOrArchivePageOrItemPage> <h2 class="sidebar-title">Archives</h2> <ul class="archive-list"> <li><a href="http://isaachobart.blogspot.com/2008/11/">November 2008</a></li> <li><a href="http://isaachobart.blogspot.com/2011/05/">May 2011</a></li> <li><a href="http://isaachobart.blogspot.com/2012/01/">January 2012</a></li> <li><a href="http://isaachobart.blogspot.com/2013/03/">March 2013</a></li> <li><a href="http://isaachobart.blogspot.com/2013/04/">April 2013</a></li> <li><a href="http://isaachobart.blogspot.com/2013/05/">May 2013</a></li> <li><a href="http://isaachobart.blogspot.com/2013/06/">June 2013</a></li> <li><a href="http://isaachobart.blogspot.com/2013/08/">August 2013</a></li> <li><a href="http://isaachobart.blogspot.com/2013/09/">September 2013</a></li> <li><a href="http://isaachobart.blogspot.com/2013/10/">October 2013</a></li> <li><a href="http://isaachobart.blogspot.com/2013/11/">November 2013</a></li> <li><a href="http://isaachobart.blogspot.com/2014/01/">January 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/03/">March 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/04/">April 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/05/">May 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/06/">June 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/07/">July 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/08/">August 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/09/">September 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/10/">October 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/11/">November 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2014/12/">December 2014</a></li> <li><a href="http://isaachobart.blogspot.com/2015/01/">January 2015</a></li> <li><a href="http://isaachobart.blogspot.com/2015/04/">April 2015</a></li> <li><a href="http://isaachobart.blogspot.com/2015/05/">May 2015</a></li> <li><a href="http://isaachobart.blogspot.com/2015/07/">July 2015</a></li> <li><a href="http://isaachobart.blogspot.com/2015/08/">August 2015</a></li> <li><a href="http://isaachobart.blogspot.com/2015/10/">October 2015</a></li> <li><a href="http://isaachobart.blogspot.com/2016/06/">June 2016</a></li> <li><a href="http://isaachobart.blogspot.com/2016/09/">September 2016</a></li> <li><a href="http://isaachobart.blogspot.com/2017/01/">January 2017</a></li> <li><a href="http://isaachobart.blogspot.com/2017/02/">February 2017</a></li> <li><a href="http://isaachobart.blogspot.com/2017/03/">March 2017</a></li> <li><a href="http://isaachobart.blogspot.com/2017/04/">April 2017</a></li> <li><a href="http://isaachobart.blogspot.com/2017/09/">September 2017</a></li> <li><a href="http://isaachobart.blogspot.com/2017/10/">October 2017</a></li> <li><a href="http://isaachobart.blogspot.com/2017/11/">November 2017</a></li> <li><a href="http://isaachobart.blogspot.com/2017/12/">December 2017</a></li> <li><a href="http://isaachobart.blogspot.com/2018/01/">January 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/02/">February 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/03/">March 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/04/">April 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/05/">May 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/06/">June 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/07/">July 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/08/">August 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/09/">September 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/10/">October 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/11/">November 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2018/12/">December 2018</a></li> <li><a href="http://isaachobart.blogspot.com/2019/01/">January 2019</a></li> <li><a href="http://isaachobart.blogspot.com/2019/02/">February 2019</a></li> <li><a href="http://isaachobart.blogspot.com/2019/03/">March 2019</a></li> <li><a href="http://isaachobart.blogspot.com/2019/04/">April 2019</a></li> <li><a href="http://isaachobart.blogspot.com/2019/07/">July 2019</a></li> <li><a href="http://isaachobart.blogspot.com/2019/09/">September 2019</a></li> <li><a href="http://isaachobart.blogspot.com/2019/10/">October 2019</a></li> <li><a href="http://isaachobart.blogspot.com/2019/11/">November 2019</a></li> <li><a href="http://isaachobart.blogspot.com/2020/01/">January 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/02/">February 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/03/">March 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/04/">April 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/05/">May 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/06/">June 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/07/">July 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/08/">August 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/09/">September 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/10/">October 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/11/">November 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2020/12/">December 2020</a></li> <li><a href="http://isaachobart.blogspot.com/2021/01/">January 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/02/">February 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/03/">March 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/04/">April 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/05/">May 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/06/">June 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/07/">July 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/08/">August 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/09/">September 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/10/">October 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/11/">November 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2021/12/">December 2021</a></li> <li><a href="http://isaachobart.blogspot.com/2022/01/">January 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/02/">February 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/03/">March 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/04/">April 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/05/">May 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/06/">June 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/07/">July 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/08/">August 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/09/">September 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/10/">October 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/11/">November 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2022/12/">December 2022</a></li> <li><a href="http://isaachobart.blogspot.com/2023/01/">January 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/02/">February 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/03/">March 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/04/">April 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/05/">May 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/06/">June 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/07/">July 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/08/">August 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/09/">September 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/10/">October 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/11/">November 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2023/12/">December 2023</a></li> <li><a href="http://isaachobart.blogspot.com/2024/01/">January 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/02/">February 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/03/">March 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/04/">April 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/05/">May 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/06/">June 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/07/">July 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/08/">August 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/09/">September 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/10/">October 2024</a></li> <li><a href="http://isaachobart.blogspot.com/2024/11/">November 2024</a></li> </ul> <p id="powered-by"><a href="http://www.blogger.com"><img src="http://buttons.blogger.com/bloggerbutton1.gif" alt="Powered by Blogger" ></a></p> <p><a href="http://www.geckoandfly.com"><img src="http://photos1.blogger.com/blogger/7994/1253/1600/make_money_online_blogspot_template.4.jpg" alt="make money online blogger templates" width="88" height="31" border="0" longdesc="http://www.geckoandfly.com/blogspot-templates" /></a></p> </MainOrArchivePageOrItemPage>  </div></div>  </div>   <div id="footer"><hr /> <p align="center"><small><span class="footer">© 2006 </span></small> <a href="http://isaachobart.blogspot.com/" title="tampa criminal attorney">tampa criminal attorney</a> | <a href="http://www.bbcok.com">Health Body guide</a> <br> </span><span class="style3">No part of the content or the blog may be reproduced without prior written permission. <br> Learn how to <a href="http://www.web-hosting-lead.com">make money with web hosting</a>.</span></p> </div>  </body> </html>

tampa criminal attorney

lead tampa criminal attorney

Halloween Predator Warning 3xm4

Wednesday, October 31, 2018

Halloween Predator Warning

Tuesday, October 30, 2018

Confirmation us-concealed

Monday, October 29, 2018

Confirmation us-concealed

Confirmation nqdc

Sunday, October 28, 2018